In a groundbreaking development, Naselin, a leading nasal decongestant brand by Cipla Health Ltd., has launched first-of-its-kind Naselin Anti-Viral Nasal Spray with Povidone Iodine to protect against coronavirus and respiratory tract infections. Research shows that Povidone Iodine can act as the first line of defence against the SARS-CoV-2 virus that causes COVID 19. With powerful antiviral properties, the spray is suitable for wide use, especially by the high risk category of essential service workers.
Povidone Iodine is a trusted molecule with anti-viral, anti-bacterial, and anti-fungal properties, which helps to protect from viruses and other germs that cause common upper respiratory tract illnesses like, cold, sinusitis or flu. Over the years, povidone iodine has been widely used in products such as gargle solution, ointments and creams. However its usage in a nasal spray format is a disruptive innovation by Cipla Health to ensure potential insulation at grass-root stages of infection.
The spray acts by killing the disease causing viruses and bacteria in the nose. Multiple studies have shown that cells lining the nose are a key entry point for SARS-CoV-2. The use of topical antiviral drugs at the nasal region is essential for preventive–care. Through the convenient packaging of Naselin Anti-Viral Nasal Spray, Povidone Iodine offers an easy and powerful means of protection against COVID.
With normalcy returning, health authorities are now emphasizing on following all safety protocols when stepping out of the house. This has spiked the demand for relevant healthcare products; nasal care being one of them. To cater to this demand, Cipla health’s Naselin Anti-Viral Nasal Spray is designed as an everyday aid.
The Naselin Anti- Viral Spray ensures its relevance beyond the current COVID context to any other respiratory tract discomfort. The 15ml spray bottle is priced at Rs. 99 and is available across 700 Apollo and Medplus pharmacy in Maharashtra, Andhra Pradesh and Telengana as well as online e-commerce platforms such as 1mg, Pharmeasy.
Commenting on the launch of the landmark product, Mr. Shivam Puri, CEO – Cipla Health Ltd. said, “At Cipla Health, we have always endeavored to bring products that can make healthcare easy and affordable. With a strong commitment to Research & Development, our products have demonstrated effectiveness against a host of health conditions to help people with speedy recovery. In line with this commitment, we are delighted to bring to our consumers one of the most innovative and effective product formulations for preventive care against coronavirus. Adding Naselin Anti-Viral Nasal Spray to our regular routine along with wearing mask, washing hands, and maintaining social distance can definitely help us to fight this pandemic together.”
About Cipla Health and Naselin:
Cipla Health Ltd. (CHL), the consumer healthcare subsidiary of Cipla Ltd. was founded in the year 2016, with a vision to become the most preferred consumer healthcare brand in India. With an already vast customer-base, the company believes in consistent innovation, and aims to make a difference to the consumer’s everyday life. CHL offers a folio of diverse brands, including Nicotex, Cofsils, Prolyte, Mamaxpert, Maxirich, Clocip, Naselin, Ciphands, Cipladine among others. Naselin is a leading nasal decongestant brand by Cipla Health Ltd. that has its flagship Nasal Decongestant spray containing Oxymetazoline Hydrochloride which helps in quick relief from blocked nose & relief of sinus congestion, thus providing you a wider area of relief. The brand has ventured into new product formulations to cater to the evolving needs of consumers.